SaberVet Avian Influenza Virus H7 Antigen Rapid Test

Sabervet Avian Influenza Virus H7 Antigen Rapid Test Sold by Antigenne is a lateral flow immunoassay intended for the qualitative detection of specific antigen from Avian Influenza Virus H7 (AIV H7) in laryngeal secretions/cloaca swab sample. The test is useful for determination of AIV H7 infection.

Follew us at:

Description

The H7 antigen in Avian Influenza Virus (AIV) is another important serotype, especially subtypes such as H7N9, which significantly affects both poultry and humans.

 

Characteristics and antigenicity

Characteristics

Genomic structure:

The H7 antigen belongs to the Influenza A Virus, whose genome consists of eight single-stranded negative-stranded RNA segments, each encoding one or more proteins.

The H7 antigen mainly involves the Hemagglutinin (HA) protein, which is responsible for viral adhesion and entry into host cells.

Hemagglutinin protein:

The HA protein is a glycoprotein on the surface of the virus and is classified into 16 serotypes (H1-H16), of which H7 is one.

HA proteins are responsible for binding to receptors on the surface of host cells and mediate viral entry into the cell.

Antigenic variation: Avian influenza viruses are susceptible to antigenic drift and antigenic switching, leading to the emergence of new subtypes and epidemics.

H7N9 is one of the most representative and pathogenic H7 subtypes.

Immunogenicity: H7 antigens are highly immunogenic and can induce the host to produce neutralising antibodies against HA proteins.

Neutralising antibodies prevent the virus from entering host cells, thus providing immune protection.

Cross-reactivity: There may be some cross-immunity between different H7 subtypes, but usually the cross-protection is limited. Immune escape is more prevalent due to antigenic variation, posing a challenge to vaccine development.

 

Clinical symptoms and disease severity

Symptoms in poultry

Highly pathogenic avian influenza (HPAI):

Acute onset: onset within a short period of time after infection, with a rapid course of the disease.

High mortality: Mortality rate up to 90-100%, especially in chickens and turkeys.

Typical symptoms: depression, loss of appetite, respiratory distress, dysentery, haemorrhage and oedema of the crown and meat beard.

Low Pathogenic Avian Influenza (LPAI):

Mild symptoms: mild respiratory symptoms such as coughing, sneezing, tearing.

Decrease in egg production: significant decrease in egg production in infected hens.

Human symptoms

Flu-like symptoms: fever, cough, sore throat, muscle aches, headache.

Severe symptoms: severe pneumonia, acute respiratory distress syndrome, multiple organ failure.

Highly pathogenic H7 subtype infected people deteriorate rapidly and have a high mortality rate.

 

Routes of transmission

Direct contact:

Poultry-to-poultry transmission: transmitted through direct contact with infected poultry or their secretions and excretions.

Human-poultry contact: humans are infected with the virus through direct contact with infected poultry or their secretions and excretions.

Environmental transmission:

The virus can be spread indirectly through contaminated water, feed, utensils, etc.

Airborne:

The virus can be transmitted through airborne droplets, especially in confined and poorly ventilated environments.

 

Clinical Diagnosis

Clinical symptom observation:

Initial diagnosis is based on typical symptoms in poultry or humans.

Laboratory Tests:

PCR: Detection of viral RNA in respiratory samples by reverse transcription PCR (RT-PCR) is a rapid and sensitive test.

Virus isolation: Virus is isolated from sick birds or patient samples for culture and identification of the virus.

Serological testing: Detection of antibodies in serum using haemagglutination inhibition (HI) or enzyme-linked immunosorbent assay (ELISA) for assessment of infection and immune response.

Rapid diagnostic reagents: Use of rapid antigen detection kits for initial screening, but laboratory confirmation is required.

 

Preventive measures

Preventive measures

Vaccination: Vaccinate poultry with avian influenza vaccines against H7 subtypes, especially in high-risk areas.

Regularly update the vaccine strain to cope with antigenic variation of the virus.

Biosecurity measures: Strictly implement biosecurity measures including quarantine of newly introduced poultry, disinfection of personnel and equipment, and restriction of entry and exit of personnel and vehicles to poultry farms.

Regularly monitor the disease situation inside and outside the poultry farm and take timely preventive and control measures.

Management Measures

All-in-all-out: Adopt an all-in-all-out feeding management mode to avoid mixing of different batches of poultry. It helps to reduce the spread of virus among poultry.

Isolation and quarantine: newly introduced poultry should be isolated and quarantined to ensure that they are not infected with H7 subtype virus. Regular health checks should be conducted to detect and treat infected poultry in a timely manner.

Personnel training: Raise awareness and preventive and control skills of keepers and veterinarians on H7 subtype avian influenza.

 

Therapeutic measures

There is no specific drug against H7 subtype avian influenza virus infection. The mainstay of treatment is symptomatic, providing supportive care and proper nutrition.

The use of antiviral drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza) may help to alleviate the symptoms but have limited effect.

 

Control measures

Culling of infected poultry: Rapidly cull infected and suspected infected poultry to prevent spread of the virus. Thoroughly clean and disinfect contaminated environment, equipment and utensils.

Strict control of poultry trade: Restrict or prohibit the trade of poultry and poultry products in areas affected by the outbreak to prevent the spread of the virus.

 

Avian Influenza Virus H7 Antigen Rapid Test

Antigenne has developed the Avian Influenza Virus H7 Antigen Rapid Test, which is a fast, easy-to-use and highly accurate test that can effectively help users to detect relevant viral infections.

FAQ

 

We offer a comprehensive range of diagnostics, including infectious disease testing, molecular diagnostics, serology, hematology, and point-of-care tests for companion animals, livestock, and poultr

 

Yes, our diagnostics meet ISO, OIE, and CE regulatory requirements where applicable.

 

Yes, we develop tailored assays and OEM solutions for laboratories and veterinary clinics. Contact our technical team for details.

 

Our test performance data is available in the product inserts, with typical sensitivity >95% and specificity >98% for most assays.

 

 Results are available in 10 minutes for lateral flow assays, and 50 minutes for Vamber test (depending on extraction and amplification time).

 

Yes, we provide free samples for qualified B2B partners. Submit a request via our website.
Yes, we offer on-site or virtual training for equipment operation, assay protocols, and data interpretation.
  Refer to our online troubleshooting guide or contact our 24/7 technical support team.
  Many assays are optimized for common platforms (e.g., Bio-Rad, Thermo Fisher). Ask for compatibility details.
Our regulatory team can provide country-specific certifications. Let us know your market requirements.

Customer Reviews

“Antigenne’s FPV Rapid Test delivers lab-grade accuracy in just 10 minutes. We’ve reduced misdiagnosis by 40% in our clinic. — Dr. Emily Wong, Paws & Claws Veterinary Hospital, USA”
cdv test
Dr. Emily Wong
Testing endangered species requires precision—Antigenne’s Avian Influenza Strips are the only ones sensitive enough for our work.” — Dr. Raj Patel, Wildlife Disease Specialist, Malaysia
testing
Dr. Raj Patel
We integrated Antigenne’s OEM lateral flow strips into our kits—zero defects in 100,000+ units shipped.” — Quality Control Lead, Animal Health Co., Netherlands
chw test
Sarah Lewis
en_USEnglish
Share to...